SOHO president looks back on 2024
For SOHO, 2024 was a year of firsts and continued growth of the society worldwide.
For SOHO, 2024 was a year of firsts and continued growth of the society worldwide.
The Board of Directors and the Steering Committee of the Society of Hematologic Oncology (SOHO) are pleased to announce that Phillip Scheinberg, MD,
Trem-cel enables repeated post-HCT maintenance dosing of gemtuzumab ozogamicin in patients with high-risk AML.
Recorded at the 66th American Society of Hematology Annual Meeting and Exposition, Yuan Yao, MD, MS, discusses the ASH abstract (No.397) titled, “Prevalence,
ASH-Gbot, an AI-driven chatbot trained on the American Society of Hematology (ASH) guidelines, is able to deliver disease-specific advice for hematological conditions with
After being postponed due to the war in the Middle East, SOHO MENA is very excited to announce that the hybrid meeting will
In this video filmed at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, Valeria Santini, MD, an associate professor of
Iryna Kriachok, MD, PhD, of the National Cancer Institute in Kyiv, Ukraine, explains in both Ukrainian and English why being invited to the
Daratumumab demonstrated a clinically meaningful and significant benefit compared with active monitoring, the current standard of care, for patients with high-risk smoldering multiple
Peihua Lu, MD, of Beijing Lu Daopei Institute of Hematology in China, stopped by the SOHO booth to speak with SOHO Insider during